Abbvie Inc.

ABBV's Fundamental analysis

Abbvie's sales fell by -0.28 % in II. Quarter 2019 from the same quarter a year ago. Ranking at No. 2461

Biotechnology & Drugs industry recorded growth of revenues by 0.68 %

Abbvie's net profit deacreased by -62.63 % in II. Quarter 2019 year on year, to $741 millions.

• More on ABBV's Growth

ABBV's Valuation comparisons

Abbvie
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Company is currently trading with Price to Cash flow multiple of 86.72 in trailing twelve-month period.

Company

34.74

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 4.32.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.87.

• More on ABBV's Valuation

Total Debt (Millions $)	37,260
Dividend TTM ($)	4.08 $
Dividend Yield TTM (%)	4.52 %
Revenue/Employee (TTM) $	1,254,769
Net Income/Employee (TTM) $	158,385
Receivable Turnover (TTM)	5.85
Tangible Book Value (Per Share $)	-30.10

ABBV's Valuation comparisons

Company

34.74

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 4.32.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.87.

• More on ABBV's Valuation

Market Capitalization (Millions $)	140,921
Shares Outstanding (Millions)	1,484
Employees	26,000
Revenues (TTM) (Millions $)	32,624
Net Income (TTM) (Millions $)	4,118
Cash Flow (TTM) (Millions $)	1,625
Capital Exp. (TTM) (Millions $)	-640

Total Debt (Millions $)	37,260
Dividend TTM ($)	4.08 $
Dividend Yield TTM (%)	4.52 %
Revenue/Employee (TTM) $	1,254,769
Net Income/Employee (TTM) $	158,385
Receivable Turnover Ratio (TTM)	5.85
Tangible Book Value (Per Share $)	-30.10

Market Capitalization (Millions $)	140,921
Shares Outstanding (Millions)	1,484
Employees	26,000
Revenues (TTM) (Millions $)	32,624
Net Income (TTM) (Millions $)	4,118
Cash Flow (TTM) (Millions $)	1,625
Capital Exp. (TTM) (Millions $)	-640

ABBV's Profitability Comparisons

Abbvie achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2019 to 41.19 % from 38.45 % in I. Quarter.

Abbvie net profit margin of 8.98 % is currently ranking no. 17 in Biotechnology & Drugs industry, ranking no. 115 in Healthcare sector and number 1541 in S&P 500.

Profitability by Segment

	*Ratio*
• Capital Ratio (MRQ)	0.89
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.54
• Inventory Turnover Ratio (TTM)	4.22

ABBV's Profitability Comparisons

At a Glance

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

Dividend Comparisons

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar MXIM's Profile Stock Price MXIM's Financials Business Description Fundamentals Charts & Quotes MXIM's News Suppliers MXIM's Competitors Customers & Markets Economic Indicators MXIM's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071